Towarzystwo Funduszy Inwestycyjnych PZU SA’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.5K	Sell	315 -76	-19%	-$10.1K	0.01%	463
2025 Q4	$55.5K	Hold	391	–	–	0.01%	402
2025 Q3	$54.9K	Sell	391 -1,389	-78%	-$188K	0.01%	398
2025 Q2	$224K	Sell	1,780 -70	-4%	-$8.03K	0.06%	145
2025 Q1	$205K	Hold	1,850	–	–	0.07%	132
2024 Q4	$253K	Hold	1,850	–	–	0.08%	103
2024 Q3	$213K	Buy	1,850 +110	+6%	+$15.1K	0.08%	110
2024 Q2	$240K	Hold	1,740	–	–	0.09%	94
2024 Q1	$240K	Hold	1,740	–	–	0.1%	92
2023 Q4	$229K	Buy	+1,740	New	+$200K	0.11%	82
2021 Q3	$141K	Hold	1,473	–	–	0.17%	70
2021 Q2	$143K	Hold	1,473	–	–	0.17%	74
2021 Q1	$143K	Hold	1,473	–	–	0.21%	66
2020 Q4	$141K	Buy	+1,473	New	+$142K	0.15%	58